IQVIA Inc.
Rating
Updated: Sep 12, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences indust...
Latest News
23 hours ago · defenseworld.net
Contrasting IQVIA (NYSE:IQV) and Bullfrog AI (NASDAQ:BFRG)Bullfrog AI (NASDAQ: BFRG - Get Free Report) and IQVIA (NYSE: IQV - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation. Profitability This table compares Bullfrog AI and IQVIA's net
5 days ago · zacks.com
IQVIA Stock Rises 60% in 6 Months: Here's What You Should KnowIQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
11 days ago · zacks.com
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
26 days ago · zacks.com
Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
27 days ago · zacks.com
Here's Why You Should Retain IQVIA Stock in Your Portfolio NowIQV shares rise 21.7% in a month as data assets, AI-enabled technology and strong cash flow support growth despite liquidity and pricing risks.
1 month ago · defenseworld.net
BlackRock Inc. Takes Position in IQVIA Holdings Inc. $IQVBlackRock Inc. bought a new position in IQVIA Holdings Inc. (NYSE: IQV) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 14,549,693 shares of the medical research company's stock, valued at approximately $2,811,292,000. BlackRock Inc. owned about 8.84% of
1 month ago · zacks.com
IQV Stock Gains 42% in 3 Months: Here's What You Should KnowIQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.
1 month ago · zacks.com
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2 months ago · zacks.com
IQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy?Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2 months ago · zacks.com
Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists?IQV's proprietary data platform and expanding clinical research business support growth, but high debt and liquidity risks keep the investment outlook balanced.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove IQV